Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Gilead Sciences    GILD

GILEAD SCIENCES

(GILD)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Latest news on GILEAD SCIENCES
10/18GRAPHIC - TAKE FIVE : Super Saturday, Super Mario
RE
10/15New Gilead Sciences CFO Expected to Pursue More Deals to Expand Portfolio
DJ
10/15GILEAD SCIENCES INC : Change in Directors or Principal Officers, Financial State..
AQ
10/15GILEAD SCIENCES : Names Andrew Dickinson Chief Financial Officer
DJ
10/15GILEAD SCIENCES : Appoints Andrew Dickinson as Chief Financial Officer
BU
10/10GILEAD SCIENCES : Galapagos See Efficacy in Advanced Rheumatoid Arthritis Study
DJ
10/10GILEAD SCIENCES : to Release Third Quarter 2019 Financial Results on Thursday, O..
BU
10/08GILEAD SCIENCES : Submits New Drug Application for Filgotinib for the Treatment ..
BU
10/07Gilead Sciences Names Merdad Parsey Chief Medical Officer
DJ
10/07GILEAD SCIENCES : Appoints Merdad Parsey, MD, PhD as Chief Medical Officer
BU
10/07GILEAD SCIENCES : Presents New Data From the Company's HIV Clinical Development ..
AQ
10/04GILEAD SCIENCES : U.S. Food and Drug Administration Approves Descovy for HIV Pre..
AQ
10/04GILEAD SCIENCES INC. : - U.S. Food and Drug Administration Approves Descovy for ..
AQ
10/04GILEAD SCIENCES : Presents New Data From the Company's HIV Clinical Development ..
BU
10/03GILEAD SCIENCES : Says FDA Approves Descovy for HIV Pre-Exposure Prophylaxis
DJ
10/03GILEAD SCIENCES : U.S. Food and Drug Administration Approves Descovy® for HIV Pr..
BU
09/16A Plan to Fight Hep C -- WSJ
DJ
09/12GILEAD SCIENCES : Ex-dividend day for
FA
09/09GILEAD SCIENCES : and the Elton John AIDS Foundation Launch RADIAN Initiative to..
BU
08/29GILEAD SCIENCES : An amendment to a SC 13D filing
PU
08/29AGENUS : Triggers 3rd Milestone in its Collaboration with Gilead
AQ
08/27GILEAD SCIENCES INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/26GILEAD SCIENCES : to Present at the Morgan Stanley Global Healthcare Conference ..
BU
08/26GILEAD SCIENCES : Alberta Provides Access to Biktarvy® for the Treatment of HIV
AQ
08/26GILEAD SCIENCES : And galapagos complete closing of their transformative researc..
AQ
08/22GSK's long acting HIV injection gets boost from study
RE
08/21GILEAD SCIENCES : Statement on Petitions to U.S. Patent and Trademark Office on ..
PU
08/19Who is next in big pharma's merger spree?
RE
08/16GILEAD SCIENCES : European Medicines Agency Validates Marketing Application for ..
AQ
08/15European Medicines Agency Reviews Arthritis Treatment by Gilead, Galapagos
DJ
08/15STEALTH BIOTHERAPEUTICS : Reports First Half 2019 Financial Results and Recent B..
AQ
08/15GILEAD SCIENCES : Québec Provides Access to Biktarvy® for the Treatment of HIV
AQ
08/12GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
AQ
08/12GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
AQ
08/09MARKET SNAPSHOT: Dow Ends Friday Trade Lower But Indexes Chipped Away At Ugly..
DJ
08/09GILEAD SCIENCES : China National Medical Products Administration Approves Biktar..
BU
08/08GILEAD SCIENCES : Statement on U.S. Food and Drug Administration Advisory Commit..
AQ
08/08AGENUS : FDA Accepts AGEN2373 IND, Triggering $7.5 Million Milestone
DJ
08/07NOVARTIS : Medicare Moves to Cover Costly Cell Therapies
DJ
08/07GILEAD SCIENCES : Statement on U.S. Food and Drug Administration Advisory Commit..
BU
08/07GILEAD SCIENCES : Medicare to cover expensive cancer cell therapies
RE
08/07Patient groups push back against Gilead's pricey HIV prevention treatment
RE
08/07ASSEMBLY BIOSCIENCES : Shares Rise as Gilead Vet Takes Helm
DJ
08/06GILEAD SCIENCES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AN..
AQ
08/06GILEAD SCIENCES : Ontario Provides Access to Biktarvy® for the Treatment of HIV
BU
07/31GLOBAL MARKETS LIVE : Apple, EssilorLuxottica, Air France, KLM…
07/30GILEAD SCIENCES : Expensive Gilead, Novartis cancer therapies losing patients to..
RE
07/30GILEAD SCIENCES : Revises Some of Its 2019 Guidance
DJ
07/30GILEAD SCIENCES : Posts Higher 2Q Earnings, Sales
DJ
07/30GILEAD : 2Q Earnings Snapshot
AQ
07/30GILEAD SCIENCES INC : Results of Operations and Financial Condition, Financial S..
AQ
07/30GILEAD SCIENCES : Announces Third Quarter 2019 Dividend
BU
07/30GILEAD SCIENCES : Announces Second Quarter 2019 Financial Results
BU
07/30GLOBAL MARKETS LIVE : Apple, Capital One, Beyond Meat, Netflix…
07/24GILEAD SCIENCES : Announces Latest Data in Ongoing HIV Cure Research Program New..
AQ
07/24GILEAD SCIENCES : Presents New Findings on Profile of Descovy for Potential Use ..
AQ
07/23GILEAD SCIENCES : Filing by person(s) reporting owned shares of common stock in ..
PU
07/23GILEAD SCIENCES : Releases Data From HIV Cure Research Program on Vesatolimod, G..
DJ
07/23GILEAD SCIENCES : Announces Latest Data in Ongoing HIV Cure Research Program
BU
07/23GILEAD SCIENCES : Presents New Findings on Profile of Descovy® for Potential Use..
BU
07/23GILEAD SCIENCES : Presents New Data on Biktarvy for the Treatment of HIV in Wome..
AQ
07/22GILEAD SCIENCES : Presents New Data on Biktarvy® for the Treatment of HIV in Wom..
BU
07/22GILEAD SCIENCES : Says Study of GS-6207 Showed HIV Capsid Inhibition Can Lead Vi..
DJ
07/22GILEAD SCIENCES : Presents Proof-of-Concept Data for GS-6207, a First-in-Class C..
BU
07/22GILEAD SCIENCES : Licenses Respiratory and Herpes Antiviral Research Programs fr..
AQ
07/22GILEAD SCIENCES : Licenses Durect's Saber Technology for Injectable HIV Product
DJ
07/19GILEAD SCIENCES : Murad Ali Shah says his government working hard to contain spr..
AQ
07/19SINDH GOVT ALLOCATES RS 600M TO CONT : CM Sindh
AQ
07/19Gilead Licenses Respiratory, Herpes Antiviral Research Programs From Novartis
DJ
07/19GILEAD SCIENCES : Licenses Respiratory and Herpes Antiviral Research Programs Fr..
BU
07/19GILEAD SCIENCES : Sindh govt allocates Rs600m to contain HIV, says Murad
AQ
07/18GILEAD SCIENCES INC : Entry into a Material Definitive Agreement, Financial Stat..
AQ
07/18GILEAD SCIENCES : to Present New Data on HIV Prevention, Treatment and Cure Rese..
BU
07/18GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave the Company
AQ
07/17GILEAD SCIENCES : Chief Scientific Officer John McHutchison to Leave
DJ
1  2  3  4  5  6  7  8  9  10Next
Official Publications
10/15Dividends 
08/29Report 
08/23SEC Filing 8K 
08/20Report 
08/13Report 
07/30Dividends 
Upcoming event on GILEAD SCIENCES